改造的iPSC衍生的天然杀手细胞:最近的翻译性先天抗癌免疫疗法的创新
Jane Sun1, Melissa Elliott1, Fernando Souza-Fonseca-Guimaraes1
1Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences The University of Queensland Brisbane QLD Australia.
Clinical & translational immunology
|July 14, 2025
概括
诱导多能干细胞 (iPSC) 为自然杀手细胞 (NK) 提供了可扩展和一致的来源,增强了它们在癌症免疫治疗中的潜力. 这些iPSC衍生的NK细胞的基因改造提高了它们的疗效和向能力,用于未来的癌症治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 癌症治疗 癌症治疗
背景情况:
- 自然杀手 (NK) 细胞是癌症免疫疗法的强有力的瘤杀伤剂.
- 使用NK细胞的全基采用细胞疗法在可扩展性和一致性方面面临挑战.
- 诱导多能干细胞 (iPSCs) 为细胞疗法提供了可控制和无穷无尽的来源.
研究的目的:
- 在定义的培养系统中审查生成iPSC衍生的NK细胞的进展.
- 突出基因修饰策略,以增强iPSC-NK细胞治疗.
- 研究iPSC-NK细胞在下一代免疫疗法中的潜力.
主要方法:
- 关于iPSC衍生NK细胞生成的近期发展情况的回顾.
- 对iPSC-NK细胞的基因改造技术的分析.
- 讨论iPSC银行和临床试验进展情况.
主要成果:
- 定义的培养系统使得来自iPSC的NK细胞的受控生成成为可能.
- 基因改造改善了iPSC-NK细胞癌症向,扩张,持久性和细胞毒性.
- iPSC-NK细胞在体外和体内都显示出增强的疗效.
结论:
- 来自iPSC的NK细胞代表了可扩展和有效的癌症免疫治疗的有希望的平台.
- 对iPSCs的基因工程对于优化基于iNK细胞的疗法至关重要.
- 进一步的开发和临床试验正在探索iPSC-NK细胞在癌症治疗中的潜力.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Cytotoxic T Cells-mediated Immune Response
2.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.3K


